01349.HK 股價走勢圖
FUDANZHANGJIANG (01349.HK)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
HK$2.71
-3.9%
$-0.1
休市： Apr 28, 16:00:00 HKT
返回
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (01349.HK)
關鍵數據
前收市價
$2.79
開盤價
$2.82
當日範圍
$2.71 - $2.82
52週區間
$2.39 - $5.29
交易量
1.1M
平均成交量
1.7M
股息收益率
--
每股盈餘 (TTM)
-0.03
市值
$921.4M
什麼是 FUDANZHANGJIANG？
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shanghai, Shanghai and currently employs 925 full-time employees. The company went IPO on 2002-08-13. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The firm's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The firm conducts its businesses in the domestic market.
